Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.05 | 0.2 |